Author
Sara Mallatt, Director of Healthcare Research
Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.
Most-Favored-Nation Policy: Implications for European Drug Launches
The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
Navigating Biopharma Policy
Biopharma firms are grappling with a turbulent and complex policy landscape.
Is FDA's Real-Time CRL Disclosure a Boon or Bane?
With the help of Tegus Expert Insights and other tools available in AlphaSense, let’s dive into the FDA’s CRL decision and the market implications.
Biotech M&A: Trends and 2026 Outlook
Now, a surge in M&A is reversing the trend as Big Pharma turns to acquisitions to offset patent losses and fuel innovation.
Biotech M&A: Trends and 2026 Outlook
We use the AlphaSense platform to explore M&A trends in biotech, key drivers, and market implications.
AI in Drug Discovery & Development
Hype, Reality, and What Comes Next
Hinge Health and the Digital Health Market | An AlphaSense Primer
Monitor competitors, track market trends, and stay ahead with AlphaSense dashboards. Turn information overload into actionable insights fast.
The Impact of Tariffs on Healthcare: Medical Devices and Pharma at Greatest Risk
Using insights from the AlphaSense platform, we analyze the expected impact of tariffs on the healthcare sector, particularly medical devices and pharma.
Biotech and Pharma M&A: 2025 Outlook
Using the AlphaSense platform, we dive into the biotech and pharma M&A landscape, including the headwinds and tailwinds affecting deals this year.
5 Pharma Industry Trends to Watch in 2025
Discover the top trends shaping the rapidly evolving pharmaceutical landscape in 2025, as well as how you can stay on top of new developments.
2025 Healthcare Outlook: Uncertainty and Innovation
We dive into AlphaSense expert interviews to uncover the top trends shaping the healthcare landscape in 2025.
Expert Insights: CAR T-Cell Therapy Breaking New Ground in Autoimmune Disease
Using our proprietary expert insights, we dive into CAR T-cell therapy as a breakthrough treatment for autoimmune disease and its evolving applications in the healthcare space.
Expert Insights: AI Adoption in Healthcare Delivery
We use first-person insights from our expert transcript library to explore the opportunities and challenges of AI adoption in healthcare delivery.
Expert Insights: How Artificial Intelligence is Transforming Drug Development
We use AlphaSense’s Expert Insights content set to discover how AI is reshaping drug development in the pharmaceutical industry.
Transform intelligence
into advantage
Develop bold strategies, seize opportunities, and lead with clarity and confidence.